Feedback / Questions
THEO-260 - Theolytics
https://www.globenewswire.com/news-release/2024/11/19/2983294/0/en/Theolytics-Doses-First-Patient-in-Phase-I-IIa-Trial-of-THEO-260-in-Ovarian-Cancer.html
Nov 19, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next